Goldman Sachs’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $52.6M | Buy |
|
|||||
|
2020
Q4 | $3.84M | Buy |
|
|||||
|
2020
Q3 | $737K | Sell |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $112K | Sell |
|
|||||
|
2019
Q4 | $400K | Buy |
|
|||||
|
2019
Q3 | $333K | Sell |
|
|||||
|
2019
Q2 | $1.51M | Buy |
|
|||||
|
2019
Q1 | $1.73M | Sell |
|
|||||
|
2018
Q4 | $1.2M | Sell |
|
|||||
|
2018
Q3 | $2.77M | Buy |
|
|||||
|
2018
Q2 | $3.01M | Sell |
|
|||||
|
2018
Q1 | $3.95M | Buy |
|
|||||
|
2017
Q4 | $3.36M | Buy |
|
|||||
|
2017
Q3 | $2.56M | Sell |
|
|||||
|
2017
Q2 | $6.22M | Sell |
|
|||||
|
2017
Q1 | $7.86M | Buy |
|
|||||
|
2016
Q4 | $4.5M | Sell |
|
|||||
|
2016
Q3 | $34.3M | Buy |
|
|||||
|
2016
Q2 | $7.46M | Buy |
|
|||||
|
2016
Q1 | $3.56M | Sell |
|
|||||
|
2015
Q4 | $7.46M | Buy |
|
|||||
|
2015
Q3 | $571K | Sell |
|
|||||
|
2015
Q2 | $1.08M | Buy |
|
|||||
|
2015
Q1 | $459K | Buy |
|
|||||
|
2014
Q4 | $284K | Sell |
|
|||||
|
2014
Q3 | $5.56M | Sell |
|
|||||
|
2014
Q2 | $7.88M | Buy |
|
|||||
|
2014
Q1 | $9.89M | Buy |
|
|||||
|
2013
Q4 | $8.04M | Buy |
|